Deutsche Bank Aktiengesellschaft Initiates Coverage on Immunocore (NASDAQ:IMCR)
Deutsche Bank Aktiengesellschaft assumed coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a note issued to investors on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $65.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s target price indicates a potential upside of 106.41% from the company’s previous close. Other […]
